Hong Kong · Delayed Price · Currency is HKD Kontafarma China Holdings Statistics
Total Valuation
HKG:1312 has a market cap or net worth of HKD 190.01 million. The enterprise value is 220.24 million.
| Market Cap | 190.01M |
| Enterprise Value | 220.24M |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1312 has 5.59 billion shares outstanding.
| Current Share Class | 5.59B |
| Shares Outstanding | 5.59B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.90B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| PB Ratio | 0.45 |
| P/TBV Ratio | 0.60 |
| P/FCF Ratio | 9.92 |
| P/OCF Ratio | 4.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.75, with an EV/FCF ratio of 11.50.
| EV / Earnings | n/a |
| EV / Sales | 0.26 |
| EV / EBITDA | 9.75 |
| EV / EBIT | n/a |
| EV / FCF | 11.50 |
Financial Position
The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.45.
| Current Ratio | 0.83 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | 8.40 |
| Debt / FCF | 9.91 |
| Interest Coverage | -6.51 |
Financial Efficiency
Return on equity (ROE) is -47.17% and return on invested capital (ROIC) is -11.30%.
| Return on Equity (ROE) | -47.17% |
| Return on Assets (ROA) | -3.55% |
| Return on Invested Capital (ROIC) | -11.30% |
| Return on Capital Employed (ROCE) | -11.54% |
| Weighted Average Cost of Capital (WACC) | 4.08% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | -340,486 |
| Employee Count | 625 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 4.39 |
Taxes
In the past 12 months, HKG:1312 has paid 51.25 million in taxes.
| Income Tax | 51.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.00% in the last 52 weeks. The beta is 0.00, so HKG:1312's price volatility has been lower than the market average.
| Beta (5Y) | 0.00 |
| 52-Week Price Change | -15.00% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 57.16 |
| Average Volume (20 Days) | 1,506,900 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1312 had revenue of HKD 845.33 million and -212.80 million in losses. Loss per share was -0.04.
| Revenue | 845.33M |
| Gross Profit | 437.76M |
| Operating Income | -61.09M |
| Pretax Income | -193.83M |
| Net Income | -212.80M |
| EBITDA | -36.04M |
| EBIT | -61.09M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 67.62 million in cash and 189.76 million in debt, with a net cash position of -122.14 million or -0.02 per share.
| Cash & Cash Equivalents | 67.62M |
| Total Debt | 189.76M |
| Net Cash | -122.14M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | 418.29M |
| Book Value Per Share | 0.09 |
| Working Capital | -80.68M |
Cash Flow
In the last 12 months, operating cash flow was 38.80 million and capital expenditures -19.64 million, giving a free cash flow of 19.15 million.
| Operating Cash Flow | 38.80M |
| Capital Expenditures | -19.64M |
| Depreciation & Amortization | 25.05M |
| Net Borrowing | -56.89M |
| Free Cash Flow | 19.15M |
| FCF Per Share | 0.00 |
Margins
Gross margin is 51.79%, with operating and profit margins of -7.23% and -25.17%.
| Gross Margin | 51.79% |
| Operating Margin | -7.23% |
| Pretax Margin | -22.93% |
| Profit Margin | -25.17% |
| EBITDA Margin | -4.26% |
| EBIT Margin | -7.23% |
| FCF Margin | 2.27% |
Dividends & Yields
HKG:1312 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -112.00% |
| FCF Yield | 10.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 20, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Jan 20, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
HKG:1312 has an Altman Z-Score of -0.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.05 |
| Piotroski F-Score | 3 |